Reuters logo
BRIEF-Achillion Pharmaceuticals Q4 revenue $15 million
February 23, 2017 / 9:34 PM / 9 months ago

BRIEF-Achillion Pharmaceuticals Q4 revenue $15 million

Feb 23 (Reuters) - Achillion Pharmaceuticals Inc

* Achillion reports 2016 fourth quarter and year-end financial results

* Sees FY 2017 loss per share $0.70 to $0.75

* Q4 revenue $15 million

* Q4 revenue view $0 -- Thomson Reuters I/B/E/S

* Expects that research and development expenses during 2017 will be approximately $75 - 80 million

* Net cash used in operating activities in 2017 will be approximately $70 - 75 million

* FY2017 earnings per share view $-0.40 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below